CD200 and B-cell chronic lymphocytic leukemia: Similar to the reduction in CD200 expression observed on CLL cells, a dose-dependent reduction in the frequencies of peripheral CD200+ CD4+ T cells was also observed, with transient responses at low doses (50–200 mg/m2) and sustained responses at higher doses (300–500 mg/m2).